MRA Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $536K | Sell |
2,890
-549
| -16% | -$102K | 0.25% | 63 |
|
|
2025
Q1 | $721K | Buy |
3,439
+292
| +9% | +$61.2K | 0.38% | 34 |
|
|
2024
Q4 | $559K | Buy |
3,147
+155
| +5% | +$27.5K | 0.3% | 42 |
|
|
2024
Q3 | $591K | Buy |
2,992
+16
| +0.5% | +$3.16K | 0.32% | 40 |
|
|
2024
Q2 | $510K | Buy |
2,976
+383
| +15% | +$65.7K | 0.29% | 45 |
|
|
2024
Q1 | $472K | Buy |
2,593
+654
| +34% | +$119K | 0.28% | 50 |
|
|
2023
Q4 | $300K | Sell |
1,939
-741
| -28% | -$115K | 0.2% | 65 |
|
|
2023
Q3 | $400K | Sell |
2,680
-559
| -17% | -$83.3K | 0.29% | 68 |
|
|
2023
Q2 | $436K | Buy |
3,239
+226
| +8% | +$30.4K | 0.3% | 56 |
|
|
2023
Q1 | $480K | Buy |
3,013
+615
| +26% | +$98K | 0.35% | 53 |
|
|
2022
Q4 | $388K | Sell |
2,398
-205
| -8% | -$33.1K | 0.3% | 67 |
|
|
2022
Q3 | $360K | Sell |
2,603
-143
| -5% | -$19.8K | 0.31% | 69 |
|
|
2022
Q2 | $421K | Buy |
2,746
+140
| +5% | +$21.5K | 0.37% | 62 |
|
|
2022
Q1 | $422K | Buy |
2,606
+23
| +0.9% | +$3.72K | 0.32% | 64 |
|
|
2021
Q4 | $350K | Sell |
2,583
-3,692
| -59% | -$500K | 0.27% | 71 |
|
|
2021
Q3 | $677K | Buy |
6,275
+383
| +7% | +$41.3K | 0.58% | 41 |
|
|
2021
Q2 | $664K | Sell |
5,892
-334
| -5% | -$37.6K | 0.57% | 40 |
|
|
2021
Q1 | $674K | Buy |
6,226
+175
| +3% | +$18.9K | 0.63% | 38 |
|
|
2020
Q4 | $648K | Buy |
+6,051
| New | +$648K | 0.64% | 38 |
|